Roads to the development of improved pertussis vaccines paved by immunology
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Roads to the development of improved pertussis vaccines paved by immunology
Authors
Keywords
-
Journal
Pathogens and Disease
Volume 73, Issue 8, Pages ftv067
Publisher
Oxford University Press (OUP)
Online
2015-09-08
DOI
10.1093/femspd/ftv067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Pertussis-Specific Effector Memory T Cells in Preschool Children
- (2015) Lia de Rond et al. Clinical and Vaccine Immunology
- Ex vivo peptide-MHC II tetramer analysis reveals distinct end-differentiation patterns of human pertussis-specific CD4+ T cells following clinical infection
- (2015) Wanda G.H. Han et al. CLINICAL IMMUNOLOGY
- Biosynthetically engineered lipopolysaccharide as vaccine adjuvant
- (2015) Afshin Zariri et al. Expert Review of Vaccines
- Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity
- (2015) René H. M. Raeven et al. JOURNAL OF PROTEOME RESEARCH
- Modulation of the CD4+ T cell response after acellular pertussis vaccination in the presence of TLR4 ligation
- (2015) Jolanda Brummelman et al. VACCINE
- Bordetella pertussis Proteins Dominating the Major Histocompatibility Complex Class II-Presented Epitope Repertoire in Human Monocyte-Derived Dendritic Cells
- (2014) Rachel M. Stenger et al. Clinical and Vaccine Immunology
- Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage
- (2014) S. W. Martin et al. CLINICAL INFECTIOUS DISEASES
- Langerhans cells promote early germinal center formation in response toLeishmania-derived cutaneous antigens
- (2014) Nicole Zimara et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012
- (2014) A Zeddeman et al. Eurosurveillance
- Adenylate cyclase toxin-hemolysin relevance for pertussis vaccines
- (2014) Peter Sebo et al. Expert Review of Vaccines
- Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacy
- (2014) Kerrie Vaughan et al. HUMAN IMMUNOLOGY
- Cyclic AMP-Mediated Suppression of Neutrophil Extracellular Trap Formation and Apoptosis by the Bordetella pertussis Adenylate Cyclase Toxin
- (2014) Joshua C. Eby et al. INFECTION AND IMMUNITY
- Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis Differently Modulate Human Dendritic Cell Functions Resulting in Divergent Prevalence of Th17-Polarized Responses
- (2014) G. Fedele et al. JOURNAL OF IMMUNOLOGY
- A critical role for the TLR signaling adapter Mal in alveolar macrophage-mediated protection against Bordetella pertussis
- (2014) N J Bernard et al. Mucosal Immunology
- A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine
- (2014) A Dunne et al. Mucosal Immunology
- Loss of Multi-Epitope Specificity in Memory CD4+ T Cell Responses to B. Pertussis with Age
- (2014) Wanda G. H. Han et al. PLoS One
- A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers
- (2014) Rigmor Thorstensson et al. PLoS One
- Live Attenuated B. pertussis BPZE1 Rescues the Immune Functions of Respiratory Syncytial Virus Infected Human Dendritic Cells by Promoting Th1/Th17 Responses
- (2014) Ilaria Schiavoni et al. PLoS One
- Molecular Signatures of the Evolving Immune Response in Mice following a Bordetella pertussis Infection
- (2014) René H. M. Raeven et al. PLoS One
- A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells
- (2014) N. Iijima et al. SCIENCE
- TCR signal quantity and quality in CD4+ T cell differentiation
- (2014) Noah J. Tubo et al. TRENDS IN IMMUNOLOGY
- Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice
- (2014) Pascal F. Feunou et al. VACCINE
- Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes
- (2014) María Emilia Gaillard et al. VACCINE
- Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination
- (2014) M. J. Bart et al. mBio
- Differential T- and B-Cell Responses to Pertussis in Acellular Vaccine-Primed versus Whole-Cell Vaccine-Primed Children 2 Years after Preschool Acellular Booster Vaccination
- (2013) Rose-Minke Schure et al. Clinical and Vaccine Immunology
- Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States
- (2013) L. C. Pawloski et al. Clinical and Vaccine Immunology
- Reduced Risk of Pertussis Among Persons Ever Vaccinated With Whole Cell Pertussis Vaccine Compared to Recipients of Acellular Pertussis Vaccines in a Large US Cohort
- (2013) Maxwell A. Witt et al. CLINICAL INFECTIOUS DISEASES
- Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin
- (2013) F. R. MOOI et al. EPIDEMIOLOGY AND INFECTION
- Pertactin-Negative Variants of Bordetella pertussis in the United States
- (2013) Anne Marie Queenan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Priming with Whole-Cell versus Acellular Pertussis Vaccine
- (2013) Juventila Liko et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers
- (2013) N. P. Klein et al. PEDIATRICS
- Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
- (2013) J. M. Warfel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Can vaccine legacy explain the British pertussis resurgence?
- (2013) Maria A. Riolo et al. VACCINE
- A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response againstBordetella pertussis
- (2013) Catpagavalli Asokanathan et al. Human Vaccines & Immunotherapeutics
- Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine
- (2013) Pádraig J. Ross et al. PLoS Pathogens
- IgG subclass profiles in normal human sera of antibodies specific to five kinds of microbial antigens
- (2013) Astrid Hjelholt et al. Pathogens and Disease
- Bordetella pertussisentry into respiratory epithelial cells and intracellular survival
- (2013) Yanina Lamberti et al. Pathogens and Disease
- T-Cell Responses before and after the Fifth Consecutive Acellular Pertussis Vaccination in 4-Year-Old Dutch Children
- (2012) Rose-Minke Schure et al. Clinical and Vaccine Immunology
- Appearance of Bordetella pertussis Strains Not Expressing the Vaccine Antigen Pertactin in Finland
- (2012) Alex-Mikael Barkoff et al. Clinical and Vaccine Immunology
- Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin
- (2012) N. Hegerle et al. CLINICAL MICROBIOLOGY AND INFECTION
- Resurgence of pertussis calls for re-evaluation of pertussis animal models
- (2012) Arno AJ van der Ark et al. Expert Review of Vaccines
- Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection
- (2012) Sarah L. Sheridan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- LAPCs promote follicular helper T cell differentiation of Ag-primed CD4+T cells during respiratory virus infection
- (2012) Jae-Kwang Yoo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates
- (2012) J M Warfel et al. Mucosal Immunology
- Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children
- (2012) Nicola P. Klein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan
- (2012) Nao Otsuka et al. PLoS One
- Mice, men and the relatives: cross-species studies underpin innate immunity
- (2012) C. E. Bryant et al. Open Biology
- Cutting Edge: Tissue-Retentive Lung Memory CD4 T Cells Mediate Optimal Protection to Respiratory Virus Infection
- (2011) J. R. Teijaro et al. JOURNAL OF IMMUNOLOGY
- Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children
- (2011) Lotte H. Hendrikx et al. VACCINE
- Intracellular Trafficking of Bordetella pertussis in Human Macrophages
- (2010) Y. A. Lamberti et al. INFECTION AND IMMUNITY
- Pertussis Toxin Up-regulates Angiotensin Type 1 Receptors through Toll-like Receptor 4-mediated Rac Activation
- (2010) Motohiro Nishida et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inflammasome Activation by Adenylate Cyclase Toxin Directs Th17 Responses and Protection against Bordetella pertussis
- (2010) A. Dunne et al. JOURNAL OF IMMUNOLOGY
- Variability in the Lipooligosaccharide Structure and Endotoxicity amongBordetella pertussisStrains
- (2010) Nico Marr et al. JOURNAL OF INFECTIOUS DISEASES
- Global, regional, and national causes of child mortality in 2008: a systematic analysis
- (2010) Robert E Black et al. LANCET
- Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory
- (2010) Rachel M. Stenger et al. VACCINE
- Cellular Immune Responses of Preterm Infants after Vaccination with Whole-Cell or Acellular Pertussis Vaccines
- (2009) F. Vermeulen et al. Clinical and Vaccine Immunology
- CD11c+CD8 + Dendritic Cells Promote Protective Immunity to Respiratory Infection with Bordetella pertussis
- (2009) P. J. Dunne et al. JOURNAL OF IMMUNOLOGY
- Murine Responses to Endotoxin: Another Dirty Little Secret?
- (2009) Robert S. Munford JOURNAL OF INFECTIOUS DISEASES
- First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin
- (2009) V. Bouchez et al. VACCINE
- The role of Toll-like receptor-4 in pertussis vaccine-induced immunity
- (2008) Sander Banus et al. BMC IMMUNOLOGY
- Pathology and Pathogenesis of FatalBordetella pertussisInfection in Infants
- (2008) Christopher D. Paddock et al. CLINICAL INFECTIOUS DISEASES
- Role of Neutrophils in Response to Bordetella pertussis Infection in Mice
- (2008) C. Andreasen et al. INFECTION AND IMMUNITY
- Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells
- (2008) Fionnuala B. Hickey et al. JOURNAL OF LEUKOCYTE BIOLOGY
- SAFETY OF A FIFTH DOSE OF DIPHTHERIA AND TETANUS TOXOID AND ACELLULAR PERTUSSIS VACCINE IN CHILDREN EXPERIENCING EXTENSIVE, LOCAL REACTIONS TO THE FOURTH DOSE
- (2008) Margaret B. Rennels et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model
- (2008) Nico Marr et al. VACCINE
- Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: Modification of vaccine-induced immune responses
- (2008) Jeroen Geurtsen et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started